Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies

Cristina Catarino1, Irene Rebelo, Luís Belo

  • 1Instituto Biologia Molecular e Celular, Universidade Porto, Portugal. tinacris_cat@hotmail.com

Thrombosis Research
|April 4, 2008
PubMed

Insights

Maternal and cord blood show similar hemostatic changes in preeclampsia, suggesting endothelial dysfunction is the cause. These changes correlate with preeclampsia severity and impact fetal birth weight.

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Vascular Biology

Background:

  • Preeclampsia (PE) involves endothelial cell activation or damage, potentially causing hemostatic changes.
  • Understanding maternal and fetal hemostatic disturbances in PE is crucial.

Purpose of the Study:

  • To investigate the relationship between maternal and umbilical cord blood hemostatic disturbances in preeclamptic pregnancies.
  • To assess the role of endothelial dysfunction in PE-related hemostatic alterations.

Main Methods:

  • Measured plasma levels of tissue plasminogen activator (tPA) antigen, plasminogen activator inhibitor type 1 (PAI-1) antigen, and D-dimer in maternal and umbilical cord blood.
  • Compared levels between uncomplicated pregnancies (n=42) and preeclamptic pregnancies (n=44).

Main Results:

  • Umbilical cord blood in PE cases showed higher tPA and a lower PAI-1/tPA ratio.
  • Preeclamptic women had elevated maternal tPA and PAI-1 levels compared to controls; D-dimer showed no significant difference.
  • Proteinuria correlated positively with maternal tPA and PAI-1 levels.
  • Maternal tPA levels inversely correlated with fetal birth weight in PE.

Conclusions:

  • Maternal hemostatic disturbances in PE mirror those in umbilical cord blood, pointing to endothelial dysfunction as the likely cause.
  • Maternal hemostatic markers, tPA and PAI-1, are associated with PE severity.
  • Further research is needed to validate tPA and PAI-1 as markers for PE severity.

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Fetal Circulation01:14

Fetal Circulation

Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...